183 related articles for article (PubMed ID: 330971)
21. Combined modality therapy of malignant melanoma.
Hersh EM; Gutterman JU; McBride CM
World J Surg; 1979 Jul; 3(3):329-43. PubMed ID: 382647
[No Abstract] [Full Text] [Related]
22. Surgical adjuvant therapy for malignant melanoma.
Pinsky CM; Oettgen HF
Surg Clin North Am; 1981 Dec; 61(6):1259-66. PubMed ID: 7031933
[No Abstract] [Full Text] [Related]
23. Malignant melanoma: an update.
Mandel MA
Clin Plast Surg; 1980 Jul; 7(3):379-96. PubMed ID: 7438705
[No Abstract] [Full Text] [Related]
24. Melanoma management.
Rampen FH
Clin Dermatol; 1992; 10(1):105-10. PubMed ID: 1504923
[No Abstract] [Full Text] [Related]
25. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy of malignant melanoma.
Vosika GJ
Minn Med; 1979 Jul; 62(7):515-7. PubMed ID: 386072
[No Abstract] [Full Text] [Related]
27. Immunotherapy of metastatic cancer in guinea pigs: failure of intralesional BCG to influence the results of radical surgery.
Hunter JT; Okuda T; Rapp HJ
J Natl Cancer Inst; 1977 Nov; 59(5):1435-9. PubMed ID: 909107
[TBL] [Abstract][Full Text] [Related]
28. Axillary lymphadenopathy: a complication of BCG immunotherapy for melanoma.
Briggs PC; Heckler FR
Plast Reconstr Surg; 1988 Jun; 81(6):952-3. PubMed ID: 3375359
[TBL] [Abstract][Full Text] [Related]
29. [Drug clinics. How I treat cutaneous melanoma].
Piérard-Franchimont C; Piérard GE
Rev Med Liege; 1998 Jan; 53(1):4-6. PubMed ID: 9555173
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide.
Elias EG; Suter CM; Fabian DS
J Surg Oncol; 1997 Jan; 64(1):17-22. PubMed ID: 9040795
[TBL] [Abstract][Full Text] [Related]
31. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
32. Immunology and cutaneous malignant melanoma.
Sober AJ
Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
[No Abstract] [Full Text] [Related]
33. Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases.
Morton DL; Eilber FR; Holmes EC; Ramming KP
Aust N Z J Surg; 1978 Feb; 48(1):49-52. PubMed ID: 276348
[TBL] [Abstract][Full Text] [Related]
34. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
Coates AS; Peters M
Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
[TBL] [Abstract][Full Text] [Related]
35. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
36. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR
Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
[TBL] [Abstract][Full Text] [Related]
37. Recent Changes and Innovations in Melanoma Treatment: A Review.
Sabag N; Yakobson A; Silberstein E
Isr Med Assoc J; 2020 Nov; 11(22):704-710. PubMed ID: 33249792
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
39. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis].
Wolf M; Menzel W
Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658
[No Abstract] [Full Text] [Related]
40. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.
Comis RL; Carter SK
Cancer Treat Rev; 1974 Dec; 1(4):285-304. PubMed ID: 4619579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
